Dravet Syndrome, also known as Severe Myoclonic Epilepsy Infancy (SMEI), is a rare epileptic disorder beginning in infancy. It is often characterized by temperature-sensitive seizures and febrile seizures (seizures associated with fevers) that may be difficult to treat. It affects males and females equally and affects an estimated 1 in 15,700 individuals in the United States. Dravet Syndrome is a lifelong disorder that can be associated with severe complications and decreased quality of life. The mortality rate ranges from 3.7-17.5% with 15-61% of deaths attributed to sudden unexpected death in epilepsy (SUDEP). However, with proper treatment and care, seizure activity can be reduced, and quality of life can be improved.